Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises.
Explor Target Antitumor Ther. 2022;3(6):746-762. doi: 10.37349/etat.2022.00111. Epub 2022 Dec 22.
Explor Target Antitumor Ther. 2022.
PMID: 36654823
Free PMC article.
Review.